Matsumoto K - Search Results

1

Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.

Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Saeki A, et al. Among authors: matsumoto k. Int J Mol Med. 2004 Jan;13(1):111-6. Int J Mol Med. 2004. PMID: 14654980

2

Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.

Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K. Ishikawa H, et al. Among authors: matsumoto k. Hepatology. 2003 Mar;37(3):696-704. doi: 10.1053/jhep.2003.50077. Hepatology. 2003. PMID: 12601367

3

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. Ohata K, et al. Among authors: matsumoto k. Cancer. 2003 Jun 15;97(12):3036-43. doi: 10.1002/cncr.11427. Cancer. 2003. PMID: 12784339 Free article.

4

Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.

Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K. Matsumoto K, et al. Hepatology. 2004 Jul;40(1):252-9. doi: 10.1002/hep.20259. Hepatology. 2004. PMID: 15239109

5

Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.

Goto T, Ishikawa H, Matsumoto K, Nishimura D, Kusaba M, Taura N, Shibata H, Miyaaki H, Ichikawa T, Hamasaki K, Nakao K, Maeshima Y, Eguchi K. Goto T, et al. Among authors: matsumoto k. Int J Oncol. 2008 Jul;33(1):33-40. Int J Oncol. 2008. PMID: 18575748 Free article.

6

Short interfering RNA-directed inhibition of hepatitis B virus replication.

Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Hamasaki K, et al. Among authors: matsumoto k. FEBS Lett. 2003 May 22;543(1-3):51-4. doi: 10.1016/s0014-5793(03)00400-9. FEBS Lett. 2003. PMID: 12753904 Free article.

7

DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.

Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, Fukuta M, Kawashimo H, Goto T, Taura N, Ichikawa T, Hamasaki K, Nakao K, Umezawa K, Eguchi K. Nishimura D, et al. Among authors: matsumoto k. Int J Oncol. 2006 Sep;29(3):713-9. Int J Oncol. 2006. PMID: 16865289

8

Gadolinium-enhanced magnetic resonance imaging in experimental facial nerve paralysis.

Nakao Y, Matsumoto K, Ochi M, Kumagami H. Nakao Y, et al. Among authors: matsumoto k. Eur Arch Otorhinolaryngol. 1994 Dec:S349-52. doi: 10.1007/978-3-642-85090-5_125. Eur Arch Otorhinolaryngol. 1994. PMID: 10774393 No abstract available.

9

Observation of motoneurons after recovery from experimental facial nerve paralysis.

Matsumoto K, Nakao Y, Kumagami H. Matsumoto K, et al. Eur Arch Otorhinolaryngol. 1994 Dec:S410-2. doi: 10.1007/978-3-642-85090-5_156. Eur Arch Otorhinolaryngol. 1994. PMID: 10774407 No abstract available.

10

Altered distribution of motor neurons in experimental facial nerve paralysis.

Nakao Y, Matsumoto K, Kumagami H. Nakao Y, et al. Among authors: matsumoto k. Acta Otolaryngol. 1992 Nov;112(6):998-1003. doi: 10.3109/00016489209137501. Acta Otolaryngol. 1992. PMID: 1481671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,562 results

Search Page

Filters